MARKET

SGMOQ

SGMOQ

Sangamo Therapeutics Inc
OTCID
0.070
+0.002
+2.94%
Opening 10:44 07/17 EDT
OPEN
0.068
PREV CLOSE
0.068
HIGH
0.070
LOW
0.063
VOLUME
139.03K
TURNOVER
9.36K
52 WEEK HIGH
0.766
52 WEEK LOW
0.030
MARKET CAP
29.00M
P/E (TTM)
-0.1829
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SGMOQ last week (0706-0710)?
Weekly Report · 4d ago
Weekly Report: what happened at SGMOQ last week (0629-0703)?
Weekly Report · 07/06 09:02
Sangamo Shares Shift to OTC Market Amid Bankruptcy
TipRanks · 07/01 20:50
Weekly Report: what happened at SGMOQ last week (0622-0626)?
Weekly Report · 06/29 09:02
Sangamo amends 8-K to file asset purchase agreement exhibits
PUBT · 06/23 20:42
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Benzinga · 06/23 17:46
Sangamo files for restructuring, plans asset sales to Lilly, Astellas
TipRanks · 06/23 16:21
Sangamo Therapeutics Initiates Chapter 11 and Asset Sales
TipRanks · 06/23 14:06
More
About SGMOQ
Sangamo Therapeutics, Inc. is a genomic medicine company. The Company’s zinc finger (ZF) epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid engineering platform has demonstrated the ability to expand delivery beyond available intrathecal delivery capsids, including in the central nervous system (CNS), in preclinical studies. Zinc finger technologies are derived from naturally occurring human proteins. They are composed of a DNA-binding domain, which binds with precision to any sequence of DNA, and various functional domains (such as nucleases and transcription factors) based on therapeutic needs. Its pipeline includes Chronic Neuropathic Pain - ST-503 and Isaralgagene civaparvovec (ST-920). ST-503 is an investigational epigenetic regulator for the treatment of intractable pain due to iSFN, a type of chronic neuropathic pain. ST-920 is a wholly owned gene therapy product candidate for the treatment of Fabry disease.

Webull offers Sangamo Therapeutics Inc stock information, including OTCID: SGMOQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGMOQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGMOQ stock methods without spending real money on the virtual paper trading platform.